missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Human TGF-beta 3 Recombinant Protein
Description
Purity: >98% by SDS-PAGE and HPLC, Endotoxin Concentration: <0.1 ng/μg, Protein Length: 112 aa (2 identical subunits), Biological Activity: ED50 ≤0.05 ng/mL, Molecular Weight: 17.5 kDa
Transforming growth factor beta 3 (TGF beta 3) is the third member of the transforming growth factor family of cytokines, which also includes TGF beta 1 and beta 2. These cytokines are secreted in precursor form consisting of a bioactive C-terminal domain attached to an N-terminal domain known as latency associated protein (LAP). Cleavage of LAP results in the mature protein, which functions as a disulfide-linked homodimer. As with all members of the family, TGF beta 3 is highly conserved across species, with mouse and human TGF beta 3 demonstrating 100% sequence homology and cross-species activity.The members of this family can be expressed by most cell types and exert pleiotropic effects, which include the suppression of B- and T-cell effector activity, mediation of tissue healing, and suppression of tumor proliferation. The promotion of CD4+CD25+ T-cell expansion is a newly discovered function of the TGF beta cytokines, and indicates an important role in the protection against autoimmunity.
Specifications
Specifications
| Accession Number | P10600 |
| For Use With (Application) | Control, ELISA, Functional Assay, Immunohistochemistry, Western Blot |
| Formulation | 0.12% acetic acid with 20% ethanol and no preservative |
| Gene ID (Entrez) | 7043 |
| Molecular Weight (g/mol) | 25.4 kDa |
| Name | Human TGF-beta 3 |
| Purification Method | Sequential Chromatography |
| Quantity | 5 μg |
| Source | Human |
| Endotoxin Concentration | <0.1 ng/ μg |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?